MedTrace Logo

Does Hyperbaric Oxygen Therapy Lead to a Sustained Increase in Insulin Sensitivity?

NCT02136615 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2015-12-02

No results posted yet for this study

Summary

In a recent series of studies performed by our group, we have shown that exposure to hyperbaric oxygen (HBOT) leads to an increase in insulin sensitivity in male subjects and that this improvement can be measured in all men, not just those with diabetes. The aim of this study is to investigate the time course of this effect and explore the mechanisms involved when exposure to HBOT induces an increase in peripheral insulin sensitivity.

Aims:

1. To determine whether the insulin sensitising effect of HBOT is apparent 24-hours after an HBO session.
2. To examine mechanisms underpinning the increase in insulin sensitivity following HBOT.

Conditions

  • Overweight and Obesity
  • Insulin Sensitivity

Sponsors & Collaborators

  • Australasian Hyperbaric & Diving Medicine Research Trust

    collaborator UNKNOWN

  • University of Adelaide

    lead OTHER

Principal Investigators

  • Leonie K Heilbronn, PhD · University of Adelaide, Discipline of Medicine

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136615 on ClinicalTrials.gov